Fundraising FoxAcurion
1 known investors
Find your way into Acurion
Sign up to see every warm intro you have to Acurion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Acurion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acurion Health develops OncoGaze, a technology that predicts clinically actionable genomic biomarkers from routine digital histology tissue slides at the biopsy stage. It serves oncologists by identifying morphological patterns in tissue images to speed up biomarker screening and guide precision cancer therapy.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeed RoundApr 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Acurion do?
- Acurion Health develops OncoGaze, a technology that predicts clinically actionable genomic biomarkers from routine digital histology tissue slides at the biopsy stage. It serves oncologists by identifying morphological patterns in tissue images to speed up biomarker screening and guide precision cancer therapy.
- Who are Acurion's investors?
- Acurion's investors include Phase Two Ventures.